The Ribbon.Life's patient-centric focus ensures that advanced cancer patients continuously engage with our platform. Patients and their treating physicians receive decision support and access to leading therapeutics and diagnostics in return for ongoing access to their electronic medical records throughout their cancer journey.
This direct patient engagement yields continuous, prospective Real World Evidence (RWE) targeted to accelerate the development and commercialization of novel cancer treatments and combinations.
With direct-to-patient engagement through the Ribbon.Life platform, researchers can find, collect, structure, transfer and submit rich, longitudinal real-world evidence needed for their oncology studies and programs.
We empower every member on The Ribbon.Life Platform to participate in cancer research through Health Studies. Partner with us to access an engaged and relevant audience in real-time and get high quality real world data to accelerate patient-centric cancer care.
With fewer than 5% of patients able to participate in clinical trials, traditional clinical outreach is antiquated and inefficient. The Ribbon.Life's patients, oncologists and industry partners engage directly with the platform, creating a powerful resource for patients and researchers, looking for unique options and increasing enrollment and participation.